Search research articles
Contact Us
Filters
Showing results (241-250 of 256) with videos related to
Page
of 26
Sort By:
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology
|
July 17, 2021
Benchmark of thirteen bioinformatic pipelines for metagenomic virus diagnostics using datasets from clinical samples
Jutte J C de Vries, Julianne R Brown, Nicole Fischer, et al.
The Lancet. Infectious Diseases
|
August 10, 2020
STROBE-metagenomics: a STROBE extension statement to guide the reporting of metagenomics studies
Tehmina Bharucha, Clarissa Oeser, Francois Balloux, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 10, 2020
Favipiravir at high doses has potent antiviral activity in SARS-CoV-2-infected hamsters, whereas hydroxychloroquine lacks activity
Suzanne J F Kaptein, Sofie Jacobs, Lana Langendries, et al.
BMJ Open Respiratory Research
|
September 21, 2021
SARS-CoV-2 lineage B.1.1.7 is associated with greater disease severity among hospitalised women but not men: multicentre cohort study
Oliver Stirrup, Florencia Boshier, Cristina Venturini, et al.
Nature Microbiology
|
April 15, 2024
Age-specific nasal epithelial responses to SARS-CoV-2 infection
Maximillian N J Woodall, Ana-Maria Cujba, Kaylee B Worlock, et al.
Nature Microbiology
|
June 18, 2024
Author Correction: Age-specific nasal epithelial responses to SARS-CoV-2 infection
Maximillian N J Woodall, Ana-Maria Cujba, Kaylee B Worlock, et al.
The Lancet. Infectious Diseases
|
September 12, 2024
Health outcomes 3 months and 6 months after molnupiravir treatment for COVID-19 for people at higher risk in the community (PANORAMIC): a randomised controlled trial
Victoria Harris, Jane Holmes, Oghenekome Gbinigie-Thompson, et al.
BMJ Open
|
August 7, 2023
Platform adaptive trial of novel antivirals for early treatment of COVID-19 In the community (PANORAMIC): protocol for a randomised, controlled, open-label, adaptive platform trial of community novel antiviral treatment of COVID-19 in people at increased risk of more severe disease
Oghenekome Gbinigie, Emma Ogburn, Julie Allen, et al.
The Journal of Infection
|
April 25, 2021
Genetic epidemiology of SARS-CoV-2 transmission in renal dialysis units - A high risk community-hospital interface
Kathy K Li, Y Mun Woo, Oliver Stirrup, et al.
Nature Communications
|
February 23, 2024
Randomized controlled trial of molnupiravir SARS-CoV-2 viral and antibody response in at-risk adult outpatients
Joseph F Standing, Laura Buggiotti, Jose Afonso Guerra-Assuncao, et al.
Page
of 26
Search research articles
Search
Showing results (241-250 of 256) with videos related to
Sort By:
Page
of 26
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology
|
July 17, 2021
Benchmark of thirteen bioinformatic pipelines for metagenomic virus diagnostics using datasets from clinical samples
Jutte J C de Vries, Julianne R Brown, Nicole Fischer, et al.
The Lancet. Infectious Diseases
|
August 10, 2020
STROBE-metagenomics: a STROBE extension statement to guide the reporting of metagenomics studies
Tehmina Bharucha, Clarissa Oeser, Francois Balloux, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 10, 2020
Favipiravir at high doses has potent antiviral activity in SARS-CoV-2-infected hamsters, whereas hydroxychloroquine lacks activity
Suzanne J F Kaptein, Sofie Jacobs, Lana Langendries, et al.
BMJ Open Respiratory Research
|
September 21, 2021
SARS-CoV-2 lineage B.1.1.7 is associated with greater disease severity among hospitalised women but not men: multicentre cohort study
Oliver Stirrup, Florencia Boshier, Cristina Venturini, et al.
Nature Microbiology
|
April 15, 2024
Age-specific nasal epithelial responses to SARS-CoV-2 infection
Maximillian N J Woodall, Ana-Maria Cujba, Kaylee B Worlock, et al.
Nature Microbiology
|
June 18, 2024
Author Correction: Age-specific nasal epithelial responses to SARS-CoV-2 infection
Maximillian N J Woodall, Ana-Maria Cujba, Kaylee B Worlock, et al.
The Lancet. Infectious Diseases
|
September 12, 2024
Health outcomes 3 months and 6 months after molnupiravir treatment for COVID-19 for people at higher risk in the community (PANORAMIC): a randomised controlled trial
Victoria Harris, Jane Holmes, Oghenekome Gbinigie-Thompson, et al.
BMJ Open
|
August 7, 2023
Platform adaptive trial of novel antivirals for early treatment of COVID-19 In the community (PANORAMIC): protocol for a randomised, controlled, open-label, adaptive platform trial of community novel antiviral treatment of COVID-19 in people at increased risk of more severe disease
Oghenekome Gbinigie, Emma Ogburn, Julie Allen, et al.
The Journal of Infection
|
April 25, 2021
Genetic epidemiology of SARS-CoV-2 transmission in renal dialysis units - A high risk community-hospital interface
Kathy K Li, Y Mun Woo, Oliver Stirrup, et al.
Nature Communications
|
February 23, 2024
Randomized controlled trial of molnupiravir SARS-CoV-2 viral and antibody response in at-risk adult outpatients
Joseph F Standing, Laura Buggiotti, Jose Afonso Guerra-Assuncao, et al.
Page
of 26